COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (AMEX:CLN) today reported that in an article published in the Journal of the National Cancer Institute, on January 3, 2007, Duke University scientists reported results of a recent study using Celsion’s temperature sensitive liposomes in combination with heat at various times during the drug infusion.
